• Facebook
  • Twitter
  • Instagram
  • LinkedIn
  • Telegram
  • Youtube
  • otv

Tag: Bharat Biotech S Covaxin

26 Dist Have A Slower Rate In Odisha
COVID19 Vaccination  Upshot: 1 Cr In Odisha Got 2 Shots But Slow Rate In 26 Dists

Despite a faster vaccination rate in Bhubaneswar, Khordha district lags behind the South Delhi district in the inoculation race. Infection rate in Cuttack is 0.01 percent, but fully vaccinated vis-a-vis the population is below 30 per cent.

 Covaxin
Centre Approves Biotech Vax Production Facility At Ankleshwar

India's Covid vaccination coverage has crossed 51 crores cumulatively.

Covaxin Effective For 9-12 Months, No Serious Side-Effects So Far: AIIMS
Bharat Biotech Ramps Up Covaxin Production By Additional 200 Million

Bharat Biotech plans to produce 200 million doses of Covaxin per annum in the GMP facilities that are already operational for the production of vaccines based on inactivated Vero Cell Platform Technology, under stringent levels of GMP and biosafety. 

Covid-19
DCGI Approves Covaxin Clinical Trial On 2-18 Year Age Group

Following careful examination, the Drugs Controller General of India (DCGI) on Wednesday accepted the recommendation of Subject Expert Committee (SEC) and accorded permission to conduct the Phase II/III clinical trial of Covid-19 vaccine - Covaxin in the age group 2 to 18 years, to its manufacturer Bharat Biotech Ltd.

Video Icon
vaccination-in-odisha
Odisha COVID19 Vaccination Day-4: Bhubaneswar Sheds ‘Vaccine Hesitancy’ Tag, Overshoots Target!

Bhubaneswar: The big story of the Day-4 in the vaccination drive against COVID19 in Odisha is the State’s Capital city Bhubaneswar has seemingly shed the initial ‘vaccine hesitancy’ to score an over the top performance today. The Capital stride assumes significance when the vaccination rate in the whole of the State on Wednesday has been […]

COVID-Vaccine
India Approves Bharat Biotech's Covaxin, SII's Covishield COVID Vaccines For Emergency Use

New Delhi: Eleven months after the first case of deadly coronavirus was detected in India, Drug Controller General of India (DCGI) V.G. Somani on Sunday approved Bharat Biotech’s ‘Covaxin’ and Serum Institute of India’s ‘Covishield’ vaccine for emergency use, paving the way for their roll-out and administration to millions. This is a major relief for […]

scrollToTop